MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
La Revue de Médecine Interne
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

163 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
163 works in the cohort · of 4,299,418page 2 of 4

Labels cover 1 of 163 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 163 of 163 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Cardiomyopathies et antipaludéens de synthèse
M. Galliou, Laure Thomas, R. Huguet, N. Costedoat‐Chalumeau, L. Mouthon, J.S. Allain +12 more
2024· article· fr· La Revue de Médecine Interne· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Étude de phase Ib, multicentrique, en ouvert, avec escalade de dose évaluant la tolérance, la pharmacocinétique et la pharmacodynamie du mosunetuzumab administré par voie sous-cutanée chez des participants atteints d’un lupus érythémateux systémique
Z. Amoura, Vishala Chindalore, Edésio Martins, William F. Pendergraft, R. Sheng, A. Schroeder +6 more
2025· article· fr· La Revue de Médecine Interne· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Traitement par voie orale des crises d’angiœdème héréditaire (AEH) : résultats de l’étude de phase 3 KONFIDENT testant l’efficacité et la tolérance du sebetralstat pour le traitement des crises d’AEH dans la population européenne
L. Bouillet, Henriette Farkas, Emel Aygören‐Pürsün, Fotis Psarros, Maria Staevska, Markus Magerl +13 more
2025· article· fr· La Revue de Médecine Interne· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Un retraité bien «culotté»…
A. Thalabard, T. Ponge, T. Lehmann, J.-L. Vénisse, J.H. Barrier
2000· article· fr· La Revue de Médecine Interne· Health Professions
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Chez les femmes enceintes avec HTA préexistante légère, est-ce qu’une stratégie de traitement utilisant une cible de traitement < 140/90 mmHg comparativement à une surveillance sans traitement sauf si la TA > 160/105 mmHg réduit l’incidence de complications maternelles et périnatales tout en étant sécuritaire?
L. Lanthier, Nadine Sauvé, M.-É. Plourde, Michel Cauchon
2022· letter· fr· La Revue de Médecine Interne· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About